$BDPT News

BioAdaptives Highlights Michael Bisping's MyndMed(TM) Routine in UFC 331 Pre-Show Instagram Video

UFC Hall of Famer Michael Bisping Joins BioAdaptives to Champion MyndSystem(TM)

BioAdaptives, Inc. Announces CEO's Share Cancellation and Provides Capital Restructure Update

BioAdaptives Launches XcellaraHeart With Pre-Orders Ahead of August 26 Shipments

BioAdaptives Inc. Introduces XcellaraHeart(TM): the World's First Stem Cell Mobilizer with a Targeted Cardiac Homing Signal

BioAdaptives Highlights Xcellara Supply and Direction Platform for Cellular Wellness Products

BioAdaptives Explains the Scientific Basis of the Dual-Action Xcellara(TM) "Supply and Direction" Platform

BioAdaptives Opens Commercial Orders for XcellaraHeart Following Convertible Debt Retirement

BioAdaptives Inc. Opens Commercial Ordering Window for XcellaraHeart(TM) Cellular Wellness Formula

BioAdaptives Inc. Eliminates Major Market Overhang by Retiring the Debt of the Largest Convertible Commercial Investor

BioAdaptives Inc. Reports Scaling of E-Commerce Footprint and Consumer Reach for MyndSystem(TM) Nootropic Platform

BioAdaptives Completes Commercial Supply Chain Ahead of MyndSystem and Xcellara Launches

BioAdaptives Inc. Announces Operational Readiness and Completion of the Commercial Supply Chain for Upcoming Product Launches

BioAdaptives Outlines Xcellara Platform Strategy Ahead of XcellaraHeart Launch

BioAdaptives® Outlines Xcellara™ Platform Strategy: Integrating Stem Cell Supply and Direction for Targeted Wellness

BioAdaptives Announces XcellaraHeart Cardiovascular Wellness Formula Ahead of August Launch

BioAdaptives® Inc. Announces XcellaraHeart™, a Cardiovascular Wellness Formula Built on Xcellara’s Human-Clinical Data Demonstrating a 268.8% Increase in Circulating Stem/Progenitor-Type Cells

BioAdaptives Completes MyndSystem™ Platform with TruShield Certification of MyndRenew™, Securing Full WADA Compliance for Professional Athletes and Expanding Market Opportunity

BioAdaptives Launches MyndSystem™ Website — The First Supplement Platform Designed to Support Both Daytime Cognitive Performance and Overnight Brain Recovery

BioAdaptives, Inc. Launches MyndRenew™ to Complete the 24-Hour Brain Performance Cycle